M1 Macrophage-Derived Extracellular Vesicles Loaded with CX3CR1 siRNA for the Treatment of Pancreatic Cancer

Researchers investigated the therapeutic potential of siRNA specifically targeting CX3CR1 in PDAC via loading into extracellular vesicles derived from M1 macrophages, evaluating its therapeutic efficacy through in vitro and in vivo experiments.